These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 30529036)

  • 1. A tetrameric form of CD40 ligand with potent biological activities in both mouse and human primary B cells.
    Lai N; Min Q; Xiong E; Liu J; Zhang L; Yasuda S; Wang JY
    Mol Immunol; 2019 Jan; 105():173-180. PubMed ID: 30529036
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulation of cytoplasmic, surface and soluble forms of CD40 ligand in mouse B cells.
    Wykes M; Poudrier J; Lindstedt R; Gray D
    Eur J Immunol; 1998 Feb; 28(2):548-59. PubMed ID: 9521065
    [TBL] [Abstract][Full Text] [Related]  

  • 3. B cell TLR1/2, TLR4, TLR7 and TLR9 interact in induction of class switch DNA recombination: modulation by BCR and CD40, and relevance to T-independent antibody responses.
    Pone EJ; Lou Z; Lam T; Greenberg ML; Wang R; Xu Z; Casali P
    Autoimmunity; 2015 Feb; 48(1):1-12. PubMed ID: 25536171
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Hexavalent CD40 Agonist HERA-CD40L Induces T-Cell-mediated Antitumor Immune Response Through Activation of Antigen-presenting Cells.
    Merz C; Sykora J; Marschall V; Richards DM; Heinonen K; Redondo Müller M; Thiemann M; Schnyder T; Fricke H; Hill O; Gieffers C
    J Immunother; 2018; 41(9):385-398. PubMed ID: 30273198
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-CD40 Antibodies Fused to CD40 Ligand Have Superagonist Properties.
    Ceglia V; Zurawski S; Montes M; Bouteau A; Wang Z; Ellis J; Igyártó BZ; Lévy Y; Zurawski G
    J Immunol; 2021 Oct; 207(8):2060-2076. PubMed ID: 34551965
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prospects for modulating the CD40/CD40L pathway in the therapy of the hyper-IgM syndrome.
    Meng X; Yang B; Suen WC
    Innate Immun; 2018 Jan; 24(1):4-10. PubMed ID: 29132233
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunoregulatory role of CD40 in human B cell differentiation.
    Splawski JB; Fu SM; Lipsky PE
    J Immunol; 1993 Feb; 150(4):1276-85. PubMed ID: 7679424
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CD40 ligand and MHC class II expression are essential for human peripheral B cell tolerance.
    Hervé M; Isnardi I; Ng YS; Bussel JB; Ochs HD; Cunningham-Rundles C; Meffre E
    J Exp Med; 2007 Jul; 204(7):1583-93. PubMed ID: 17562816
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multimeric soluble CD40 ligand and GITR ligand as adjuvants for human immunodeficiency virus DNA vaccines.
    Stone GW; Barzee S; Snarsky V; Kee K; Spina CA; Yu XF; Kornbluth RS
    J Virol; 2006 Feb; 80(4):1762-72. PubMed ID: 16439533
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Circulating Follicular Helper and Follicular Regulatory T Cells Are Severely Compromised in Human CD40 Deficiency: A Case Report.
    Cicalese MP; Gerosa J; Baronio M; Montin D; Licciardi F; Soresina A; Dellepiane RM; Miano M; Baselli LA; Volpi S; Dufour C; Plebani A; Aiuti A; Lougaris V; Fousteri G
    Front Immunol; 2018; 9():1761. PubMed ID: 30131802
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The hyper IgM syndromes.
    Qamar N; Fuleihan RL
    Clin Rev Allergy Immunol; 2014 Apr; 46(2):120-30. PubMed ID: 23797640
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The therapeutic potential of SA-sCD40L in the orthotopic model of superficial bladder cancer.
    Zhang Z; Xu X; Zhang X; Chen X; Chen Q; Dong L; Hu Z; Li J; Gao J
    Acta Oncol; 2011 Oct; 50(7):1111-8. PubMed ID: 21247263
    [TBL] [Abstract][Full Text] [Related]  

  • 13. B cells from CBA/N mice do not proliferate following ligation of CD40.
    Hasbold J; Klaus GG
    Eur J Immunol; 1994 Jan; 24(1):152-7. PubMed ID: 7517360
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Generation of a multimeric form of CD40L with potent immunostimulatory activity using streptavidin as a chaperon.
    Kilinc MO; Mukundan L; Yolcu ES; Singh NP; Suttles J; Shirwan H
    Exp Mol Pathol; 2006 Jun; 80(3):252-61. PubMed ID: 16487512
    [TBL] [Abstract][Full Text] [Related]  

  • 15. T-BAM/CD40-L on helper T lymphocytes augments lymphokine-induced B cell Ig isotype switch recombination and rescues B cells from programmed cell death.
    Lederman S; Yellin MJ; Cleary AM; Pernis A; Inghirami G; Cohn LE; Covey LR; Lee JJ; Rothman P; Chess L
    J Immunol; 1994 Mar; 152(5):2163-71. PubMed ID: 7907632
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A cytotoxic CD40/p55 tumor necrosis factor receptor hybrid detects CD40 ligand on herpesvirus saimiri-transformed T cells.
    Hess S; Kurrle R; Lauffer L; Riethmüller G; Engelmann H
    Eur J Immunol; 1995 Jan; 25(1):80-6. PubMed ID: 7531151
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CD40 ligand and appropriate cytokines induce switching to IgG, IgA, and IgE and coordinated germinal center and plasmacytoid phenotypic differentiation in a human monoclonal IgM+IgD+ B cell line.
    Cerutti A; Zan H; Schaffer A; Bergsagel L; Harindranath N; Max EE; Casali P
    J Immunol; 1998 Mar; 160(5):2145-57. PubMed ID: 9498752
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CD40/CD40 ligand interactions in normal, reactive and malignant lympho-hematopoietic tissues.
    Gruss HJ; Herrmann F; Gattei V; Gloghini A; Pinto A; Carbone A
    Leuk Lymphoma; 1997 Feb; 24(5-6):393-422. PubMed ID: 9086433
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Membrane-bound CD154, but not CD40-specific antibody, mediates NF-kappaB-independent IL-6 production in B cells.
    Baccam M; Bishop GA
    Eur J Immunol; 1999 Dec; 29(12):3855-66. PubMed ID: 10601993
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Update on the hyper immunoglobulin M syndromes.
    Davies EG; Thrasher AJ
    Br J Haematol; 2010 Apr; 149(2):167-80. PubMed ID: 20180797
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.